Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q4 2021 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2022-02-14

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $218M (100.0% shares, 0.0% debt)

Holdings (23)

— AMRYT PHARMA PLC - SPNR ADR 30.1%

Value $65.55M Shares 6,069,775 Share Price $10.80 Est. Cost/Share $12.60 Unrealized @ Report Date —

— CTI BIOPHARMA CORP 10.0%

Value $21.82M Shares 8,800,358 Share Price $2.48 Est. Cost/Share $2.49 Unrealized @ Report Date —

XERS XERIS BIOPHARMA HOLDINGS INC 7.6%

Value $16.57M Shares 5,656,373 Share Price $2.93 * Est. Cost/Share $2.16 Unrealized @ Report Date 0.0%

ADMA ADMA BIOLOGICS INC 6.4%

Value $13.97M Shares 9,911,577 Share Price $1.41 * Est. Cost/Share $1.31 Unrealized @ Report Date 0.0%

OVID OVID THERAPEUTICS INC 5.9%

Value $12.86M Shares 4,006,185 Share Price $3.21 * Est. Cost/Share $3.44 Unrealized @ Report Date -0.5%

EOLS EVOLUS INC 5.6%

Value $12.13M Shares 1,863,096 Share Price $6.51 * Est. Cost/Share $7.42 Unrealized @ Report Date -7.6%

— CONFORMIS INC 5.2%

Value $11.24M Shares 14,768,823 Share Price $0.76 Est. Cost/Share $0.77 Unrealized @ Report Date —

XGN EXAGEN INC 4.6%

Value $9.985M Shares 858,567 Share Price $11.63 Est. Cost/Share $13.33 Unrealized @ Report Date -12.1%

— APOLLO ENDOSURGERY INC 4.5%

Value $9.704M Shares 1,151,163 Share Price $8.43 Est. Cost/Share $5.57 Unrealized @ Report Date —

— ANTARES PHARMA INC 3.8%

Value $8.202M Shares 2,297,360 Share Price $3.57 Est. Cost/Share $3.58 Unrealized @ Report Date —

— OPTINOSE INC 2.9%

Value $6.228M Shares 3,844,230 Share Price $1.62 Est. Cost/Share $1.62 Unrealized @ Report Date —

DMAC DIAMEDICA THERAPEUTICS INC 2.0%

Value $4.456M Shares 1,194,670 Share Price $3.73 * Est. Cost/Share $4.07 Unrealized @ Report Date -3.5%

ATYR ATYR PHARMA INC 1.8%

Value $3.926M Shares 525,531 Share Price $7.47 * Est. Cost/Share $6.50 Unrealized @ Report Date +28.4%

RZLT REZOLUTE INC 1.8%

Value $3.864M Shares 808,405 Share Price $4.78 * Est. Cost/Share $5.84 Unrealized @ Report Date 0.0%

CELC CELCUITY INC 1.4%

Value $3.158M Shares 239,433 Share Price $13.19 * Est. Cost/Share $20.31 Unrealized @ Report Date -21.2%

— CIDARA THERAPEUTICS INC 1.3%

Value $2.936M Shares 2,311,530 Share Price $1.27 Est. Cost/Share $1.52 Unrealized @ Report Date —

— SYNLOGIC INC 1.2%

Value $2.575M Shares 1,064,135 Share Price $2.42 Est. Cost/Share $3.01 Unrealized @ Report Date —

— AVALO THERAPEUTICS INC 1.2%

Value $2.567M Shares 1,510,095 Share Price $1.70 Est. Cost/Share $1.97 Unrealized @ Report Date —

ANIP ANI PHARMACEUTICALS INC 1.1%

Value $2.41M Shares 52,290 Share Price $46.09 * Est. Cost/Share $42.97 Unrealized @ Report Date 0.0%

— CYMABAY THERAPEUTICS INC 0.5%

Value $1.014M Shares 300,000 Share Price $3.38 Est. Cost/Share $3.38 Unrealized @ Report Date —

NMTC NEUROONE MEDICAL TECHNOLOGIES CORPORATION 0.4%

Value $967K Shares 498,354 Share Price $1.94 * Est. Cost/Share $2.70 Unrealized @ Report Date 0.0%

XOMA XOMA CORP 0.4%

Value $960K Shares 46,026 Share Price $20.86 * Est. Cost/Share $20.24 Unrealized @ Report Date +15.5%

ALDX ALDEYRA THERAPEUTICS INC 0.4%

Value $800K Shares 200,000 Share Price $4.00 * Est. Cost/Share $7.63 Unrealized @ Report Date 0.0%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
—	AMRYT PHARMA PLC - SPNR ADR	6,069,775	$65.55M	30.1%	$10.80	$12.60	—	SPONSORED ADS	03217L106
—	CTI BIOPHARMA CORP	8,800,358	$21.82M	10.0%	$2.48	$2.49	—	COM	12648L601
XERS	XERIS BIOPHARMA HOLDINGS INC	5,656,373	$16.57M	7.6%	$2.93 *	$2.16	0.0%	COM	98422E103
ADMA	ADMA BIOLOGICS INC	9,911,577	$13.97M	6.4%	$1.41 *	$1.31	0.0%	COM	000899104
OVID	OVID THERAPEUTICS INC	4,006,185	$12.86M	5.9%	$3.21 *	$3.44	-0.5%	COM	690469101
EOLS	EVOLUS INC	1,863,096	$12.13M	5.6%	$6.51 *	$7.42	-7.6%	COM	30052C107
—	CONFORMIS INC	14,768,823	$11.24M	5.2%	$0.76	$0.77	—	COM	20717E101
XGN	EXAGEN INC	858,567	$9.985M	4.6%	$11.63	$13.33	-12.1%	COM	30068X103
—	APOLLO ENDOSURGERY INC	1,151,163	$9.704M	4.5%	$8.43	$5.57	—	COM	03767D108
—	ANTARES PHARMA INC	2,297,360	$8.202M	3.8%	$3.57	$3.58	—	COM	036642106
—	OPTINOSE INC	3,844,230	$6.228M	2.9%	$1.62	$1.62	—	COM	68404V100
DMAC	DIAMEDICA THERAPEUTICS INC	1,194,670	$4.456M	2.0%	$3.73 *	$4.07	-3.5%	COM NEW	25253X207
ATYR	ATYR PHARMA INC	525,531	$3.926M	1.8%	$7.47 *	$6.50	+28.4%	COM NEW	002120202
RZLT	REZOLUTE INC	808,405	$3.864M	1.8%	$4.78 *	$5.84	0.0%	COM NEW	76200L309
CELC	CELCUITY INC	239,433	$3.158M	1.4%	$13.19 *	$20.31	-21.2%	COM	15102K100
—	CIDARA THERAPEUTICS INC	2,311,530	$2.936M	1.3%	$1.27	$1.52	—	COM	171757107
—	SYNLOGIC INC	1,064,135	$2.575M	1.2%	$2.42	$3.01	—	COM	87166L100
—	AVALO THERAPEUTICS INC	1,510,095	$2.567M	1.2%	$1.70	$1.97	—	COM	05338F108
ANIP	ANI PHARMACEUTICALS INC	52,290	$2.41M	1.1%	$46.09 *	$42.97	0.0%	COM	00182C103
—	CYMABAY THERAPEUTICS INC	300,000	$1.014M	0.5%	$3.38	$3.38	—	COM	23257D103
NMTC	NEUROONE MEDICAL TECHNOLOGIES CORPORATION	498,354	$967K	0.4%	$1.94 *	$2.70	0.0%	COM NEW	64130M209
XOMA	XOMA CORP	46,026	$960K	0.4%	$20.86 *	$20.24	+15.5%	COM NEW	98419J206
ALDX	ALDEYRA THERAPEUTICS INC	200,000	$800K	0.4%	$4.00 *	$7.63	0.0%	COM	01438T106